These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24272203)
1. Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Tumour Biol; 2014 Apr; 35(4):3327-31. PubMed ID: 24272203 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Tumour Biol; 2014 Apr; 35(4):3611-6. PubMed ID: 24310505 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Tumour Biol; 2014 Apr; 35(4):3095-102. PubMed ID: 24307621 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Tumour Biol; 2014 Apr; 35(4):3125-32. PubMed ID: 24254307 [TBL] [Abstract][Full Text] [Related]
5. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Cancer Chemother Pharmacol; 2014 Mar; 73(3):631-7. PubMed ID: 24477605 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer. Didem T; Faruk T; Senem K; Derya D; Murat S; Murat G; Oznur K Tumour Biol; 2014 Jul; 35(7):6777-82. PubMed ID: 24722824 [TBL] [Abstract][Full Text] [Related]
7. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma? Karabulut S; Akşit E; Tas F; Ciftci R; Aydiner A; Yildiz I; Keskin S; Eralp Y; Yasasever CT; Vatansever S; Disci R; Saip P Tumour Biol; 2014 May; 35(5):4323-9. PubMed ID: 24390664 [TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer. Tas F; Kilic L; Bilgin E; Keskin S; Sen F; Ciftci R; Yildiz I; Yasasever V Int J Gynecol Cancer; 2013 Feb; 23(2):276-81. PubMed ID: 23266651 [TBL] [Abstract][Full Text] [Related]
9. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC). Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774 [TBL] [Abstract][Full Text] [Related]
10. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients. Huo J; Hu J; Liu G; Cui Y; Ju Y Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129 [TBL] [Abstract][Full Text] [Related]
11. A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium. Pils D; Tong D; Hager G; Obermayr E; Aust S; Heinze G; Kohl M; Schuster E; Wolf A; Sehouli J; Braicu I; Vergote I; Van Gorp T; Mahner S; Concin N; Speiser P; Zeillinger R BMC Cancer; 2013 Apr; 13():178. PubMed ID: 23551967 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer. Kolwijck E; Span PN; Thomas CM; Bulten J; Sweep FC; Massuger LF Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124 [TBL] [Abstract][Full Text] [Related]
13. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer. Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810 [TBL] [Abstract][Full Text] [Related]
14. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer. Yildiz I; Tas F; Kilic L; Sen F; Saip P; Eralp Y; Keskin S; Karabulut S; Ciftci R; Serilmez M; Yasasever V; Aydiner A Cancer Chemother Pharmacol; 2013 Aug; 72(2):437-44. PubMed ID: 23801282 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer. Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577 [TBL] [Abstract][Full Text] [Related]
17. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. Qiu J; Yu Y; Fu Y; Ye F; Xie X; Lu W J Obstet Gynaecol Res; 2012 Apr; 38(4):651-7. PubMed ID: 22413879 [TBL] [Abstract][Full Text] [Related]
18. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer. Pylväs-Eerola M; Karihtala P; Puistola U BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer. Paek J; Lee SH; Yim GW; Lee M; Kim YJ; Nam EJ; Kim SW; Kim YT Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):338-42. PubMed ID: 21683503 [TBL] [Abstract][Full Text] [Related]
20. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. Luo Y; Kim HS; Kim M; Lee M; Song YS J Gynecol Oncol; 2017 May; 28(3):e36. PubMed ID: 28382799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]